dc.creator | Escobar, Carlos Hugo | |
dc.creator | Chaparro, Orlando | |
dc.date.accessioned | 2022-04-20T13:41:58Z | |
dc.date.accessioned | 2022-09-27T12:38:03Z | |
dc.date.available | 2022-04-20T13:41:58Z | |
dc.date.available | 2022-09-27T12:38:03Z | |
dc.date.created | 2022-04-20T13:41:58Z | |
dc.date.issued | 2016-02 | |
dc.identifier | 2157-6564 | |
dc.identifier | https://repositorio.fucsalud.edu.co/handle/001/2699 | |
dc.identifier | 2157-6580 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/3596080 | |
dc.description.abstract | Molecules of animal or bacterial origin, which pose a risk for zoonoses or immune rejection, are com-monly used for extraction, culture, and cryopreservation of mesenchymal stem cells. There is no se-quentialandorderlyprotocolforproducinghumanadipose-derivedstemcells(hASCs)underxeno-freeconditions. Afterstandardizinga humanplateletlysate (hPL) productionprotocol,four humanadiposetissue samples were processed through explants with fetal bovine serum (FBS)-supplemented or hPL-supplemented media for extracting the adipose-derived stem cells. The cells were cultivated in cellculture medium + hPL (5%) or FBS (10%). The cellular replication rate, immunophenotype, and differ-entiation potential were evaluated at fourth passage. Cellular viability was evaluated before and aftercryopreservation of the cells, with an hPL-based solution compared with an FBS-based solution. Theexplants cultured in hPL-supplemented media showed earlier and faster hASC proliferation than didthosesupplementedwithFBS.Likewise,cellsgrowninhPL-supplementedmediashowedagreaterpro-liferation rate, without losing the immunophenotype. Osteogenic differentiation of xeno-free hASCwas higher than the hASC produced in standard conditions. However, adipogenic differentiationwas reduced in xeno-free hASC. Finally, the cells cryopreserved in an hPL-based solution showed ahigher cellular viability thanthecells cryopreserved inanFBS-based.In conclusion, we have developeda complete xeno-free protocol for extracting, culturing, and cryopreserving hASCs that can be safelyimplemented in clinical studies. | |
dc.language | eng | |
dc.publisher | AlphaMed Press | |
dc.publisher | Reino Unido | |
dc.relation | Stem cells translational medicine | |
dc.relation | 365 | |
dc.relation | 3 | |
dc.relation | 358 | |
dc.relation | 5 | |
dc.relation | Stem cells translational medicine | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.rights | Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0) | |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.rights | http://purl.org/coar/access_right/c_abf2 | |
dc.source | https://stemcellsjournals.onlinelibrary.wiley.com/doi/10.5966/sctm.2015-0094 | |
dc.title | Xeno-free extraction, culture, and cryopreservation of human adipose-derived mesenchymal stem cells | |
dc.type | Artículo de revista | |